Weiva Sieh, MD, PhD, MS

About Me
Education & Certifications
Locations
Publications
Industry Relationships

About Me

Dr. Sieh’s research focuses on identifying genetic and epidemiologic factors underlying cancer susceptibility and outcomes. Current interests include:
1) Genetic and environmental determinants of mammographic breast density; relationship of breast density and other image features to breast cancer risk.
2) Genomic risk prediction using machine learning methods.
3) Risk and prognosis of hormone-related cancers, including cancers of the breast, ovary and prostate.

Language

English

Position

ADJUNCT ASSOCIATE PROFESSOR | Genetics and Genomic Sciences

About Me

Language

English

Position

ADJUNCT ASSOCIATE PROFESSOR | Genetics and Genomic Sciences

Education

BA Biology, Harvard University

MD Medicine, McGill University

MS Biostatistics, University of Washington

PhD Epidemiology, University of Washington

Postdoc Statistical Genetics, University of Washington

Locations

Icahn (East) Building Floor 4 Room 80E, 1425 Madison Ave, New York, NY, 10029

212-659-5906

Publications

Publications:145

Selected Publications

Risk of Alzheimer's Disease and Related Dementias in Persons with Glaucoma: A National Cohort Study. Casey Crump, Jan Sundquist, Weiva Sieh, Kristina Sundquist. Ophthalmology
Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white women. Laurel A. Habel, Stacey E. Alexeeff, Ninah Achacoso, Vignesh A. Arasu, Aimilia Gastounioti, Lawrence Gerstley, Robert J. Klein, Rhea Y. Liang, Jafi A. Lipson, Walter Mankowski, Laurie R. Margolies, Joseph H. Rothstein, Daniel L. Rubin, Li Shen, Adriana Sistig, Xiaoyu Song, Marvella A. Villaseñor, Mark Westley, Alice S. Whittemore, Martin J. Yaffe, Pei Wang, Despina Kontos, Weiva Sieh. Breast Cancer Research
MiXcan: a framework for cell-type-aware transcriptome-wide association studies with an application to breast cancer. Xiaoyu Song, Jiayi Ji, Joseph H. Rothstein, Stacey E. Alexeeff, Lori C. Sakoda, Adriana Sistig, Ninah Achacoso, Eric Jorgenson, Alice S. Whittemore, Robert J. Klein, Laurel A. Habel, Pei Wang, Weiva Sieh. Nature Communications

View All Publications

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Sieh did not report having any of the following types of financial relationships with industry and other outside entities during 2023 and/or 2024: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.